Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novavax Inc. stock underperforms Monday when compared to competitors
Novavax Inc. closed 67.02% below its 52-week high of $23.86, which the company achieved on June 6th.
McKnight's Long-Term Care News54m
Report: COVID-19 vaccine 33 percent effective at thwarting emergency, urgent care visits
The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...
Iowa bill asks vaccine manufacturers to waive indemnity against injury lawsuits
The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...
H.C. Wainwright Sticks to Their Hold Rating for Cassava Sciences (SAVA)
In a report released today, Vernon Bernardino from H.C. Wainwright maintained a Hold rating on Cassava Sciences (SAVA – Research Report). The ...
Vermont Business Magazine3h
VDH: COVID-19 hospitalizations in Vermont fall
Case data has become a less meaningful indicator of COVID-19 activity since individual cases are being reported in a very limited basis by health care settings and laboratories. The same is true for ...